0000950170-24-023373.txt : 20240229
0000950170-24-023373.hdr.sgml : 20240229
20240229183406
ACCESSION NUMBER: 0000950170-24-023373
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobson Mark L.
CENTRAL INDEX KEY: 0001805812
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 24705989
MAIL ADDRESS:
STREET 1: 200 BROADWAY
STREET 2: 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10038
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER, 22ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
ownership.xml
4
X0508
4
2024-02-27
0001579428
Axsome Therapeutics, Inc.
AXSM
0001805812
Jacobson Mark L.
C/O AXSOME THERAPEUTICS, INC.
ONE WORLD TRADE CENTER, 22ND FLOOR
NEW YORK
NY
10007
false
true
false
false
CHIEF OPERATING OFFICER
false
Employee Stock Option (Right to Buy)
84.00
2024-02-27
4
A
false
32825
0.00
A
2034-02-26
Common Stock
32825
32825
D
Restricted Stock Units
2024-02-27
4
A
false
18027
0.00
A
Common Stock
18027
18027
D
The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on February 27, 2028.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on February 27, 2028. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.
/s/ Mark Jacobson
2024-02-29